Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease.

Harskamp RE, Newby LK.

Ann Intern Med. 2014 Apr 15;160(8):JC9. doi: 10.7326/0003-4819-160-8-201404150-02009. No abstract available.

PMID:
24733226
2.
3.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

Rodriguez AE, Fernandez-Pereira C, Mieres J.

JAMA Intern Med. 2014 Jun;174(6):1007. doi: 10.1001/jamainternmed.2014.776. No abstract available.

PMID:
24887763
4.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease.

Takagi H, Umemoto T; ALICE Group..

JAMA Intern Med. 2014 Jun;174(6):1006-7. doi: 10.1001/jamainternmed.2014.773. No abstract available.

PMID:
24887761
5.

Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply.

Sipahi I.

JAMA Intern Med. 2014 Jun;174(6):1007-8. doi: 10.1001/jamainternmed.2014.762. No abstract available.

PMID:
24887764
6.
7.
8.

The FREEDOM trial: in appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI.

Aggarwal B, Goel SS, Sabik JF, Shishehbor MH.

Cleve Clin J Med. 2013 Aug;80(8):515-23. doi: 10.3949/ccjm.80a.13030.

9.

ACP journal club. Review: in diabetes with multivessel or left main CAD, PCI increases death/MI/stroke combo compared with CABG.

Hlatky MA.

Ann Intern Med. 2015 Mar 17;162(6):JC8. doi: 10.7326/ACPJC-2015-162-6-008. No abstract available.

PMID:
25775351
10.

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.

Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.

Circulation. 2007 Sep 11;116(11 Suppl):I200-6.

11.

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.

Circulation. 2008 Sep 9;118(11):1146-54. doi: 10.1161/CIRCULATIONAHA.107.752147. Epub 2008 Aug 25.

12.

Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.

Burgess SN, Mussap CJ, French JK.

Clin Ther. 2013 Aug;35(8):1069-75. doi: 10.1016/j.clinthera.2013.07.427. Review.

PMID:
23973040
13.

Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM.

Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.

PMID:
20643244
14.

Evolving treatment options in coronary artery disease.

Katz MH.

JAMA Intern Med. 2014 Feb 1;174(2):231. doi: 10.1001/jamainternmed.2013.7492. No abstract available.

PMID:
24296643
15.

Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease.

Bittl JA, He Y, Jacobs AK, Yancy CW, Normand SL; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..

Circulation. 2013 Jun 4;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646. Epub 2013 May 14.

16.

The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.

Taggart DP.

Eur J Cardiothorac Surg. 2013 Dec;44(6):978-9. doi: 10.1093/ejcts/ezt450. Epub 2013 Sep 18. No abstract available.

PMID:
24047712
17.

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ.

J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014.

18.

CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease.

Nicolini F, Agostinelli A, Vezzani A, Benassi F, Gherli T.

Int Heart J. 2014;55(6):469-73. Epub 2014 Oct 7. Review.

19.

Cardiac surgery versus stenting: what is better for the patient?

Edelman JJ, Wilson MK, Bannon PG, Vallely MP.

ANZ J Surg. 2012 Nov;82(11):792-8. doi: 10.1111/j.1445-2197.2012.06262.x. Epub 2012 Sep 18.

PMID:
22989330
20.

Coronary revascularization in multivessel disease. Which is better, stents or surgery?

Almeda FQ, Snell RJ.

Postgrad Med. 2005 Dec;118(6):11-7. Review.

PMID:
16382760

Supplemental Content

Support Center